Bioventus Inc.
BVS
$6.56
$0.010.15%
NASDAQ
| 06/28/2025 | 03/29/2025 | 12/31/2024 | 09/28/2024 | 06/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.91M | 22.80M | 41.58M | 43.07M | 31.99M |
| Total Receivables | 132.37M | 118.08M | 127.47M | 121.93M | 137.31M |
| Inventory | 96.47M | 94.05M | 92.48M | 90.03M | 87.61M |
| Prepaid Expenses | 13.46M | 14.44M | 14.08M | 16.92M | 23.57M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 26.73M | 28.41M |
| Total Current Assets | 275.20M | 249.37M | 275.61M | 298.69M | 308.88M |
|
|
|||||
| Total Current Assets | 275.20M | 249.37M | 275.61M | 298.69M | 308.88M |
| Net Property, Plant & Equipment | 30.74M | 32.35M | 33.52M | 39.20M | 42.30M |
| Long-term Investments | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M |
| Goodwill | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M |
| Total Other Intangibles | 386.95M | 395.73M | 404.73M | 414.81M | 424.55M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.75M | 4.75M | 4.75M | 7.40M | 6.88M |
| Total Assets | 706.79M | 691.41M | 727.96M | 769.49M | 792.17M |
|
|
|||||
| Total Accounts Payable | 24.25M | 19.20M | 23.69M | 16.85M | 24.44M |
| Total Accrued Expenses | 42.10M | 35.95M | 65.61M | 54.24M | 49.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 47.77M | 41.70M | 31.26M | 42.48M | 42.40M |
| Total Finance Division Other Current Liabilities | 71.57M | 77.91M | 89.85M | 97.92M | 115.62M |
| Total Other Current Liabilities | 71.57M | 77.91M | 89.85M | 97.92M | 115.62M |
| Total Current Liabilities | 185.68M | 174.75M | 210.40M | 211.49M | 231.46M |
|
|
|||||
| Total Current Liabilities | 185.68M | 174.75M | 210.40M | 211.49M | 231.46M |
| Long-Term Debt | 297.88M | 308.59M | 308.29M | 345.02M | 344.72M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.01M | 15.84M | 16.51M | 17.57M | 18.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.92M | 6.76M | 7.16M | 8.58M | 8.48M |
| Total Liabilities | 505.49M | 505.94M | 542.35M | 582.66M | 603.11M |
|
|
|||||
| Common Stock & APIC | 514.86M | 510.50M | 505.59M | 503.22M | 501.05M |
| Retained Earnings | -352.84M | -360.30M | -355.08M | -354.92M | -350.10M |
| Treasury Stock & Other | -774.00K | -2.06M | -2.57M | 445.00K | -17.00K |
| Total Common Equity | 161.24M | 148.14M | 147.94M | 148.74M | 150.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 161.24M | 148.14M | 147.94M | 148.74M | 150.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 40.06M | 37.34M | 37.66M | 38.10M | 38.13M |
| Total Equity | 201.30M | 185.48M | 185.60M | 186.83M | 189.06M |
|
|
|||||